{"meta":{"status":200,"messages":[],"pagination":{"max":1,"offset":0,"count":1,"total":1,"pageNum":1,"totalPages":1,"sort":null,"currentUrl":"https://api.digitalmedia.hhs.gov/api/v2/resources/media.json?offset=0&max=1&ignoreHiddenMedia=1&format=json&id=14379&newUrlBase=http://www.cdc.gov/vaccines/hcp/vis","nextUrl":null,"previousUrl":null}},"results":[{"content":"\n
\n

What's New With VISs

\n
\n
\n
\n
\n
\n
\n

Key points

\n
\n
\n

This page offers the latest information about vaccine information statements (VISs) currently under development or newly released.

\n
\n
\n
\n
\n
\n
\n
\n \n \n

2025

\n
\n
Get email updates
\n

Sign up for our email newsletter below.

\n
\n \n
\n \n \n
\n
\n
\n

May 29, 2025

\n

Updated Pneumococcal Conjugate (PCV) and Pneumococcal Polysaccharide (PPSV23) VISs Now Available

\n

Updated VISs for PCV and PPSV23 vaccines have been posted. We encourage providers to begin using these VISs immediately, but stocks of previous editions may be used until exhausted.

\n

January 31, 2025

\n

Updated VISs Now Available

\n

Updated VISs for COVID-19, dengue, hepatitis A, hepatitis B, live attenuated influenza, inactivated influenza, MMR, MMRV, meningococcal ACWY, meningococcal B, polio, respiratory syncytial virus (RSV), Tdap (tetanus, diphtheria, and pertussis), varicella, cholera, Ebola, and smallpox/monkeypox vaccines have been posted. Providers are encouraged to begin using these updated VISs immediately.

\n
\n
\n \n \n

2024

\n

October 17, 2024

\n

Updated COVID-19, Respiratory Syncytial Virus (RSV), and Cholera Vaccine VISs Now Available

\n

Updated Vaccine Information Statements for COVID-19 vaccine, RSV vaccine, and Cholera vaccine have been posted. We encourage providers to begin using these VISs immediately, but stocks of previous editions may be used until exhausted.

\n
\n
\n \n \n

2023

\n

December 7, 2023

\n

New Tick-borne Encephalitis (TBE) Vaccine VIS Now Available

\n

A new Vaccine Information Statement for TBE vaccine has been posted. We encourage providers to begin using this VIS immediately.

\n

October 19, 2023

\n

New COVID-19 and Updated Respiratory Syncytial Virus (RSV) Vaccine VISs Now Available

\n

A new Vaccine Information Statement for COVID-19 vaccine and an updated VIS for RSV vaccine have been posted. We encourage providers to begin using these VISs immediately, but stocks of previous editions may be used until exhausted.

\n

July 24, 2023

\n

New Respiratory Syncytial Virus (RSV) and Updated Multiple Vaccines (\u201cYour Child\u2019s First Vaccines\u201d) VISs Now Available

\n

A new Vaccine Information Statement for respiratory syncytial virus vaccine and an updated VIS for multiple vaccines have been posted. We encourage providers to begin using these VISs immediately, but stocks of previous editions may be used until exhausted.

\n

May 12, 2023

\n

Updated Pneumococcal Conjugate and Hepatitis B VISs Now Available

\n

Updated VISs for pneumococcal conjugate and hepatitis B vaccines have been posted. Providers are encouraged to begin using these updated VISs immediately, but stocks of the previous editions may be used until exhausted.

\n
\n
\n \n \n

2022

\n

November 16, 2022

\n

Updated Smallpox/Monkeypox VIS Now Available

\n

An updated Vaccine Information Statement for Smallpox/Monkeypox vaccine has been posted on November 16, 2022. We encourage providers to begin using this VIS immediately, but stocks of the previous edition may be used until exhausted.

\n

August 23, 2022

\n

Updated Smallpox/Monkeypox VIS Now Available

\n

An updated Vaccine Information Statement for Smallpox/Monkeypox vaccine has been posted on August 23, 2022. We encourage providers to begin using this VIS immediately, but stocks of the previous edition may be used until exhausted.

\n

June 30, 2022

\n

New Ebola VIS Now Available

\n

A new Vaccine Information Statement for Ebola vaccine has been posted on June 30, 2022. It may be used starting immediately.

\n

June 2, 2022

\n

Updated Rabies VIS Now Available

\n

An updated VIS for rabies vaccine has been posted on June 2, 2022. We encourage providers to begin using this VIS immediately, but stocks of the previous edition may be used until exhausted.

\n

June 1, 2022

\n

New Smallpox/Monkeypox VIS Now Available

\n

A new Vaccine Information Statement for Smallpox/Monkeypox vaccine has been posted on June 1, 2022. It may be used starting immediately.

\n

February 4, 2022

\n

New PCV VIS and Updated Zoster/Shingles (Recombinant) VISs Now Available

\n

A new Vaccine Information Statement for pneumococcal conjugate vaccine and an updated VIS for recombinant zoster vaccine have been posted. We encourage providers to begin using these VISs immediately, but stocks of the previous editions may be used until exhausted.

\n
    \n
  • The new pneumococcal conjugate VIS includes all currently available pneumococcal conjugate vaccines (PCV13, PCV15, and PCV20). This interim VIS replaces the previous PCV13 VIS.
    • \n
  • The updated zoster/shingles (recombinant) VIS reflects recent changes to indications for use of the vaccine.
    • \n
\n
\n
\n \n \n

2021

\n

December 17, 2021

\n

New Dengue VIS Now Available

\n

A new Vaccine Information Statement for dengue vaccine has been posted on December 17, 2021. It may be used starting immediately.

\n

October 15, 2021

\n

Updated Hepatitis A, Hepatitis B, Rotavirus, and Multi-Pediatric VISs Now Available

\n

Updated VISs for hepatitis A, hepatitis B, and rotavirus vaccines have been posted. An updated version of the \"Your Child's First Vaccines\" multiple pediatric vaccines VIS is also available now on our website. Providers are encouraged to begin using these updated VISs immediately, but stocks of the previous editions may be used until exhausted.

\n

August 6, 2021

\n

Updated VISs Now Available

\n

Updated VISs for DTaP (diphtheria, tetanus, and pertussis), Hib (Haemophilus influenzae type b), HPV (human papillomavirus), live attenuated influenza, inactivated influenza, MMR, MMRV, meningococcal ACWY, meningococcal B, PCV (pneumococcal conjugate), polio, Tdap (tetanus, diphtheria, and pertussis), Td (tetanus and diphtheria), and varicella vaccines have been posted. We encourage providers to begin using these updated VISs immediately, but stocks of the previous editions may be used until exhausted.

\n
\n
\n
\n \n \n
\n
\n
\n \n
\n
\n
\n Sources \n Print \n Share \n
\n \n \n \n \n
\n
\n
\n
\n Facebook \n LinkedIn \n Twitter \n Syndicate \n
\n
\n
\n
\n
\n Content Source: \n
\n National Center for Immunization and Respiratory Diseases; \n Immunization Services Division \n
\n
\n \n \n
\n
\n
\n
\n
\n
\n \n
Syndicated Content Details:
Source URL: http://www.cdc.gov/vaccines/hcp/vis/what-is-new.html
Source Agency: Centers for Disease Control and Prevention (CDC)
Captured Date: 2016-05-23 23:18:13.0
","description":"Refreshing browser so latest version appears and not copy saved in cache.","id":14379,"mediaType":"Html","name":"Vaccine Information Statement | Recent and Upcoming Changes | VIS","sourceUrl":"http://www.cdc.gov/vaccines/hcp/vis/what-is-new.html"}]}